HIF-1α regulates hypoxia-induced EP1 expression in osteoblastic cells

Journal of Cellular Biochemistry

Volumn 107, Issue 2, 2009, Pages 233-239

  Genetos, Damian C ^a   Lee, Christina M ^b   Wong, Alice ^b   Yellowley, Clare E ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ep1; HIF 1 ; Hypoxia; JNK; Osteoblast; SAPK

Indexed keywords

DIMETHYLOXALOGLYCINE; GLYCINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE 2; PROSTAGLANDIN E RECEPTOR; PROTEIN EP1; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; EGLN1 PROTEIN, MOUSE; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROSTANOID RECEPTOR EP1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TARGETING; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL HYPOXIA; CELL LINE; GENE EXPRESSION REGULATION; GENE SILENCING; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE KINASE 4; MICE; OSTEOBLASTS; PROCOLLAGEN-PROLINE DIOXYGENASE; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 66149088342     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22119     Document Type: Article

References (39)

1. Akeno N, Czyzyk-Krzeska MF, Gross TS, Clemens TL. 2001. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha. Endocrinology 142:959-962.
2. Brighton CT, Krebs AG. 1972. Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am 54:323-332.
3. Brochhausen C, Neuland P, Kirkpatrick CJ, Nusing RM, Klaus G. 2006. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ - Prostaglandin E2 dependent proliferation of growth plate chondrocytes. Arthritis Res Ther 8:R78.
4. Bruick RK, McKnight SL. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340.
5. Caro J. 2001. Hypoxia regulation of gene transcription. High Alt Med Biol 2:145-154.
6. Choi HJ, Eun JS, Kim BG, Kim SY, Jeon H, Soh Y. 2006. Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells. Mol Cells 22:291-299.
7. Comerford KM, Cummins EP, Taylor CT. 2004. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia. Cancer Res 64:9057-9061. (Pubitemid 39665517)
8. Conrad PW, Rust RT, Han J, Millhorn DE, Beitner-Johnson D. 1999. Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274:23570-23576.
9. Dekel S, Lenthall G, Francis MJ. 1981. Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 63-B:185-189.
10. Dodd JS, Raleigh JA, Gross TS. 1999. Osteocyte hypoxia: A novel mechanotransduction pathway. Am J Physiol 277:C598-C602.
11. Epari DR, Lienau J, Schell H, Witt F, Duda GN. 2008. Pressure, oxygen tension and temperature in the periosteal callus during bone healing - an in vivo study in sheep. Bone 43:734-739.
12. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
13. Hanson ES, Rawlins ML, Leibold EA. 2003. Oxygen and iron regulation of iron regulatory protein 2. J Biol Chem 278:40337-40342.
14. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278:30772-30780.
15. Hochachka PW, Buck LT, Doll CJ, Land SC. 1996. Unifying theory of hypoxia tolerance: Molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 93:9493-9498.
16. Irwin R, LaPres JJ, Kinser S, McCabe LR. 2007. Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype. J Cell Biochem 100:762-772.
17. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG, Jr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468.
18. Komatsu DE, Hadjiargyrou M. 2004. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34:680-688.
19. Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG. 2002. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 22:7405-7416.
20. Lee CM, Genetos DC, You Z, Yellowley CE. 2007. Hypoxia regulates PGE(2) release and EP1 receptor expression in osteoblastic cells. J Cell Physiol 212:182-188.
21. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
22. Matsuda N, Morita N, Matsuda K, Watanabe M. 1998. Proliferation and differentiation of human osteoblastic cells associated with differential activation of MAP kinases in response to epidermal growth factor, hypoxia, and mechanical stress in vitro. Biochem Biophys Res Commun 249:350-354.
23. Minet E, Michel G, Mottet D, Raes M, Michiels C. 2001. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic Biol Med 31:847-855.
24. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J. 2000. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 275:26484-26491.
25. Pettersen EO, Juul NO, Ronning OW. 1986. Regulation of protein metabolism of human cells during and after acute hypoxia. Cancer Res 46:4346-4351.
26. Raymond R, Millhorn D. 1997. Regulation of tyrosine hydroxylase gene expression during hypoxia: Role of Ca2R and PKC. Kidney Int 51:536-541.
27. Robin ED, Murphy BJ, Theodore J. 1984. Coordinate regulation of glycolysis by hypoxia in mammalian cells. J Cell Physiol 118:287-290.
28. Schipani E. 2006. Hypoxia and HIF-1alpha in chondrogenesis. Ann N Y Acad Sci 1068:66-73.
29. Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. 1997. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 239:840-844.
30. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537.
31. Simon AM, Manigrasso MB, O'Connor JP. 2002. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17:963-976.
32. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS. 2000. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor upregulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60:4873-4880.
33. Suda M, Tanaka K, Natsui K, Usui T, Tanaka I, Fukushima M, Shigeno C, Konishi J, Narumiya S, Ichikawa A, Nakao N. 1996. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 137:1698-1705.
34. Tang CH, Yang RS, Fu WM. 2005. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase C alpha, and c-Src pathway in primary cultured rat osteoblasts. J Biol Chem 280:22907-22916. (Pubitemid 40853199)
35. Towler DA. 2007. Vascular biology and bone formation: Hints from HIF. J Clin Invest 117:1477-1480.
36. Tsujisawa T, Inoue H, Nishihara T. 2005. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. J Bone Miner Res 20:15-22.
37. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, Einhorn TA, Deng L, Clemens TL. 2008. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105:686-691.
38. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL. 2007. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616-1626.
39. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.